Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply
- PMID: 31747740
- DOI: 10.1056/NEJMc1913157
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply
Comment on
-
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med. 2019 Nov 21;381(21):2075-2076. doi: 10.1056/NEJMc1913157. N Engl J Med. 2019. PMID: 31747739 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical